Skip to content
Home › 13F recaps › Q3 2026 › CRNXGBP

Which funds bought or sold CRNXGBP in Q3 2026?

Crinetics Pharmaceuticals In. 0 funds bought, 11 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$1.3B.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold CRNXGBP, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (0)

None of the tracked funds.

Sold (11)

FundChangeEst. $Now
Fidelity
Asset manager
Sold out−$593M—
BlackRock
Index giant
Sold out−$365M—
Farallon
Hedge fund
Sold out−$336M—
Wellington
Asset manager
Sold out−$267M—
Vanguard
Index giant
Sold out−$181M—
Vanguard Capital
Index giant
Sold out−$178M—
Geode
Index giant
Sold out−$102M—
State Street
Index giant
Sold out−$101M—
T. Rowe Price
Asset manager
Sold out−$75M—
Northern Trust
Bank & broker
Sold out−$36M—
Fisher Investments
Asset manager
Sold out−$28M—

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.